Table 2. Comparison of the Mean Values of the Variables Before and After the Intervention Within and Between the Control and Experimental Groupsa.
| Variables | Phase of Intervention | Experimental Group | Control Group | P Value, ANCOVA for Groups |
|---|---|---|---|---|
| Bodyweight, Kg | 0.787 | |||
| Before | 75.90 ± 8.56 | 73.81 ± 7.15 | ||
| After | 75.75 ± 8.25 | 73.65 ± 7.22 | ||
| Change, % | -0.15 ± 1.12 | -0.21 ± 2.22 | ||
| P-value | 0.225b | 0.504 | ||
| BMI, Kg/m 2 | 0.787 | |||
| Before | 27.60 ± 2.47 | 27.21 ± 2.27 | ||
| After | 27.55 ± 2.34 | 27.15 ± 2.30 | ||
| Change, % | -0.15 ± 1.12 | -0.21 ± 2.22 | ||
| P-value | 0.233 | 0.500 | ||
| SBP, mmHg | 0.556 | |||
| Before | 137.75 ± 14.5 | 132.57 ± 17.01 | ||
| After | 137.51 ± 12.27 | 132.42 ± 16.70 | ||
| Change, % | -0.04 ± 3.22 | -0.06 ± 2.06 | ||
| P-value | 0.688 | 0.707 | ||
| DBP, mmHg | 0.788 | |||
| Before | 81.62 ± 7.65 | 81.73 ± 7.01 | ||
| After | 81.42 ± 7.21 | 80.84 ± 6.83 | ||
| Change, % | -0.08 ± 3.97 | -0.24 ± 4.53 | ||
| P-value | 0.692 | 0.605 | ||
| FBS, mg/dL | 0.007 | |||
| Before | 158.37 ± 48.16 | 153.88 ± 54.76 | ||
| After | 137.91 ± 23.24 | 153.93 ± 42.06 | ||
| Change, % | -7.86 ± 21.97 | 5.05 ± 29.14 | ||
| P-value | 0.005 | 0.995 | ||
| HbA1c, % | 0.005 | |||
| Before | 7.00 ± 1.08 | 6.97 ± 1.21 | ||
| After | 6.37 ± 1.29 | 6.98 ± 1.33 | ||
| Change, % | -8.24 ± 16.77 | 1.03 ± 15.76 | ||
| P-value | 0.001 | 0.941 |
Abbreviation: BMI, Body Mass Index; DBP, Diastolic Blood Pressure; FBS, fasting blood sugar; HbA1c, hemoglobin A1c; SBP, systolic blood pressure.
aData are presented as mean ±Standard Deviation, paired sample t test and ANCOVA were used.
bP-value compared before and after intervention.